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Abstract Human monocyte-macrophages were incubated for 24 
h in Ham's F-10 medium with human low-density lipoprotein 
(LDL) in the presence or absence of ß-carotene, canthaxanthin 
or zeaxanthin, at final concentrations of 2.5, 12.5 and 25 mg/1. 
LDL oxidation, measured by agarose gel electrophoresis, the 
thiobarbituric acid assay and gas chromatography, was inhibited 
by each of the carotenoids in a concentration-dependent manner. 
Canthaxanthin was more effective when incorporated into LDL 
before addition to the cultures whereas ß-carotene and zea-
xanthin were more effective when added simultaneously with 
LDL. The results suggest that dietary carotenoids might help 
slow atherosclerosis progression. 
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1. Introduction 
Carotenoids are plant pigments which can act as antioxi-
dants, being radical scavengers and quenchers of singlet oxy-
gen [1,2]. Dietary carotenoids occur in plasma lipoproteins, 
including low-density lipoprotein (LDL) [3,4]. Epidemiologi-
cally, they are associated with protection against ischaemic 
heart disease [5,6]. L D L oxidation by macrophages is believed 
to be important in progression of atherosclerotic lesions [7,8], 
and might be inhibited by carotenoids. The present study 
assesses the abilities of the carotenoids ß-carotene, zeaxanthin 
and canthaxanthin to inhibit L D L oxidation by human mono-
cyte-derived macrophages ( H M M ) in vitro. ß-Carotene and 
zeaxanthin are common in vegetables and fruits. Cantha-
xanthin occurs in the edible mushroom Cantharellus cinnaba-
rinus and is a permissible food additive. 
Each carotenoid was tested at final concentrations of 2.5, 
12.5 and 25 mg/1. Normal ß-carotene levels in plasma are in 
the range 0.1-1.3 mg/1 (i.e. 0.2-2.5 μΜ) [9-12], and zeaxanthin 
levels are of a similar order of magnitude, depending on diet 
[11]. Canthaxanthin levels are usually much lower; it was in-
cluded mainly to help assess structure-activity relationships. 
The lower two carotenoid concentrations correspond to those 
attainable by dietary supplementation, based on ß-carotene 
studies [12,13]. The third concentration, 25 mg/1, is non-phys-
iological, being slightly above the upper limit of the supple-
mented range [12], but was included because L D L oxidation 
by macrophages is almost certainly much more rapid in vitro 
than in lesions. 
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2. Materials and methods 
ß-Carotene, zeaxanthin and canthaxanthin were gifts of F. Hoff-
mann-La Roche AG, Basel, Switzerland, and were stored in crystal-
line form at —70°C under argon. Nominal purities were respectively 
100%, 97% and 97% (by spectrophotometry) as supplied. They were 
pure judged by mass spectrometry (in the electron impact, positive 
ionisation mode), with ions consistent with the literature [14,15]. High 
resolution mass spectrometry gave accurate masses of the molecular 
ions consistent with the theoretical values. Stock solutions of caroten-
oids in HPLC-grade tetrahydrofuran (THF) (Sigma-Aldrich, Gilling-
ham, Dorset, UK) were freshly made up for each experiment, and 
were judged pure by HPLC. Carotenoids are highly soluble in THF, 
and the solutions are water-miscible, forming microemulsions, filtrable 
through a 0.2 μpiι filter, in which carotenoid molecules are surrounded 
by 'cages' of THF molecules [16]. This is an established method of 
adding carotenoids to cell cultures [16]. Each carotenoid was tested at 
final concentrations in the cultures of 2.5, 12.5 and 25 mg/1 (4.7, 23 
and 47 μΜ for ß-carotene, and 4.4, 22 and 44 μΜ for canthaxanthin 
and zeaxanthin). None of these carotenoids was cytotoxic to HMM at 
these concentrations, judged by the [3H]adenine release method [17]. 
LDL was prepared from fresh human EDTA-plasma pooled from 
at least four normal volunteers, using the method of Havel et al. 
[18]. LDL was stored at 4°C with 1 mM EDTA for no longer than 
1 month. Directly before use it was dialysed against several changes 
of phosphate-buffered saline (PBS), the protein assayed, diluted to 
1 mg LDL protein/ml with PBS, and EDTA added such that the 
resultant final concentration of EDTA in the cultures was 5 μΜ 
[19]. HMM were prepared by an established procedure [17]. Essen-
tially, venous blood (treated with 2.7 mM EDTA) from normal vol-
unteers was centrifuged on Lymphoprep separation medium (Ny-
comed AS, Oslo, Norway), and monocytes were purified by 
adherence to Falcon 24-well plastic tissue culture plates (Becton Dick-
inson UK Ltd., Cowley, Oxford, UK) in Gibco Macrophage SFM 
(serum-free medium) (Life Technologies Ltd., Paisley, Scotland, UK). 
Mononuclear cells were seeded at 3 X 106 cells per well, resulting in ca. 
0.5-1.OX 106 monocytes per well after removal of nonadherent cells. 
For LDL oxidation experiments the medium was changed to serum-
free Ham's F-10 medium (ICN Biomedicals Inc., Costa Mesa, CA, 
USA), supplemented additionally with 3 μΜ iron(II) sulphate, 10.6 
mg/1 phenol red and 1 mM glutamine [19,20]. Appropriate amounts of 
carotenoid stock solutions were either (a) added to LDL, allowed to 
equilibrate for 18 h at room temperature, and this carotenoid-supple-
mented LDL subsequently added (without reisolation) to HMM cul-
tures, or (b) added directly to HMM cultures, to which unsupplement-
ed LDL was added simultaneously. The final concentrations in the 
cultures were 160 μg LDL protein/ml, THFs0.5% (v/v), carotenoids 
as stated above. The final volume of the medium was 0.62 ml per well. 
The controls were culture medium containing LDL in the presence or 
absence of carotenoids, but no cells. For LDL oxidations in the ab-
sence of carotenoid, THF was added at 0.5% (v/v). LDL oxidations 
were terminated at 24 h by addition of EDTA (1.5 mM) and butylated 
hydroxytoluene (30 μΜ). Samples were stored at 4°C for the thiobar-
bituric acid (TBA) assay and electrophoresis, or at —20°C under 
argon for analysis by gas chromatography (GC) [19-21]. 
LDL oxidation was measured in samples of medium by (a) the TBA 
assay [21], (b) relative mobility on agarose gel electrophoresis (dis-
tance migrated by oxidised LDL divided by distance migrated by 
native LDL) using the Beckman Paragon LipoGel system (Beckman 
Instruments, Brea, CA, USA) [19,21] and (c) analysis of lipids and 
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oxidised lipids by GC [19-21], Essentially the procedure comprised 
addition of internal standards, Bligh and Dyer extraction, sodium 
borohydride reduction, saponification and derivatisation to methyl 
esters and trimethylsilyl ethers, prior to analysis by GC using a 30 
m DB-1 fused silica capillary column (J and W Scientific, Folsom, 
CA, USA) [19-21]. When LDL is oxidised, its polyunsaturated fatty 
acids, of which linoleate is the major species, become depleted, and 
7ß-hydroxycholesterol is produced [19-21]. 
Purity of carotenoid stock solutions, carotenoid uptake by cells, 
and levels in medium and in LDL, were measured by reversed-phase 
HPLC, monitoring at 460 nm, using a 1050 series HPLC system with 
a ChemStation data system (Hewlett-Packard Ltd., Stockport, Chesh-
ire, UK). The method was an adaptation of that of Nelis and De 
Leenheer [22], using a Spherisorb ODS-2 column (Phase Separations 
Ltd., Deeside, Clwyd, UK), 25 cm X 4.6 mm, particle size 5 μpiι, elut-
ing at 1.5 ml/min with isocratic methanol/acetonitrile/dichloromethane 
in the following volume proportions: 60/30/10 for canthaxanthin, 60/ 
10/30 for ß-carotene and 85/10/5 for zeaxanthin. Carotenoids were 
extracted from the medium, from cell lysates, and from LDL, using 
ethanol-hexane, with Sudan I (Sigma Chemical, Poole, Dorset, UK) 
as an internal standard. 
The level of incorporation of carotenoid was measured in LDL (1 
ml of 1 mg LDL protein/ml in PBS) which had been equilibrated for 
18 h at room temperature with canthaxanthin, zeaxanthin or ß-car-
otene (30 μΐ of a 5 mg/ml solution in THF). This represents the top 
concentration used in the main part of the study (i.e. equivalent to a 
final carotenoid concentration of 25 mg/1 in the cultures). Unincorpo-
rated carotenoid was removed using an anion-exchange column 
(DEAE Sepharose CL-6B; Sigma) eluted initially with 50 mM Tris 
buffer (pH 8), and then the LDL with its incorporated carotenoid 
eluted subsequently using 0.5 M sodium chloride. An aliquot of the 
eluted LDL was assayed for protein, and another aliquot was ex-
tracted with hexane and analysed by HPLC as above to quantitate 
carotenoids. 
3. Results and discussion 
LDL oxidation was much more in the presence of cells than 
in their absence, and carotenoids generally made little differ-
ence to the background level of LDL oxidation in the absence 
of cells, which was typically: thiobarbituric acid-reactive sub-
stances (TBARS) less than 5 nmol/mg LDL protein, relative 
electrophoretic mobility (REM) less than 1.5, 7ß-hydroxychol-
esterol less than 10 μg/mg LDL protein. Results in the pres-
ence of cells are explained below. Each experiment was re-
peated on three separate occasions, each with a different 
batch of LDL and a different donor of monocytes. Results 
varied somewhat, presumably due to individual variations in 
LDL composition and monocyte activity, but the trend was 
maintained, and a representative experiment is illustrated in 
each case. 
Canthaxanthin, added to the LDL, inhibited HMM-
mediated LDL oxidation in a concentration-dependent man-
ner, judged by TBARS, REM and GC (Fig. 1). However, 
when canthaxanthin was added to the medium at the same 
time as the LDL, negligible inhibition was seen in terms of 
TBARS and REM (Fig. la,b), or linoleate (18:2) depletion, 
though some inhibition of 7ß-hydroxycholesterol production 
was seen (Fig. lc). 
Zeaxanthin produced slight inhibition of LDL oxidation 
when added to the LDL, and marked, concentration-depend-
ent inhibition when added to the medium at the same time as 
the LDL (Fig. 2). The apparent differences in behaviour of 
these two carotenoids, i.e. zeaxanthin being more effective 
when added to the medium whereas canthaxanthin was 
more effective when added to the LDL, are in keeping with 
the polarities of the carotenoids; canthaxanthin is a diketone 
and therefore less polar than the diol zeaxanthin. However, 
ß-carotene, which is a hydrocarbon, and so even less polar 
than canthaxanthin, was more effective at inhibiting LDL 
oxidation when added to the medium than when added to 
the LDL (Fig. 3). 
Simple consideration of polarities thus does not explain all 
the differences in results. The different carotenoid species 
might preferentially scavenge different types of radicals; e.g. 
canthaxanthin might be better at scavenging lipid peroxyl rad-
icals, as in another system [23], whereas ß-carotene and zea-
xanthin might be better at scavenging thiyl radicals. The car-
otenoids' ability to quench singlet oxygen is probably 
irrelevant here. Singlet oxygen would have given rise to chol-
est-6-en-3ß,5a-diol, whereas free radicals produce 7-oxysterols 
[24], and the latter are formed in LDL oxidation by macro-
phages or copper [19-21]. 
The relative antioxidant potencies of the three carotenoids 
tested were comparable in this study. At 25 mg/1, mean per-
centage effects of ß-carotene (added to the medium), zea-
xanthin (added to the medium) and canthaxanthin (added 
via the LDL) were, respectively: 73%, 75% and 83% inhibition 
of 7ß-hydroxycholesterol production; 54%, 55% and 78% in-
hibition of depletion of linoleate; 65%, 43% and 56% inhibi-
tion of REM; and 63%, 58% and 52% inhibition of TBARS 
formation. The results imply that the carotenoids are slightly 
more effective at protecting cholesterol from oxidation than 
they are at protecting polyunsaturated fatty acids from oxida-
tion, consequent MDA formation and apo B-100 modifica-
tion. Carotenoids are rigid lipophilic molecules and so might 
tend to associate with cholesterol, either the unesterified chol-
esterol in the shell of LDL, or the cholesterol moiety of chol-
esterol esters in the core of the LDL particle. 
The effect of increasing the carotenoid concentration to 50 
mg/1 was also tested, and for canthaxanthin and zeaxanthin 
gave increased inhibition of LDL oxidation, but this was not 
extensively studied as this concentration was far above phys-
iological levels. ß-Carotene (added to the medium) gave only 
marginally more inhibition on increasing to 50 mg/1 (93 μΜ). 
Canthaxanthin at 50 mg/1 (89 μΜ; added via the LDL), gave 
84% inhibition of REM and 84% inhibition of TBARS, whilst 
zeaxanthin at 50 mg/1 (88 μΜ; added to the medium) gave 
inhibitions of 57% for REM, 86% for TBARS, and 90% for 
7ß-hydroxycholesterol. In comparison, 80 μΜ oc-tocopherol 
gave 90% inhibition of REM under similar conditions [19]; 
such a plasma level is achievable by dietary supplementation 
[12,13]. 
Results from HPLC suggested that uptake of cantha-
xanthin, zeaxanthin and ß-carotene by HMM was approxi-
mately of the order of a nanomole per 106 cells, in Ham's 
F-10 medium in the absence of LDL, for a 25 mg/1 final 
concentration in cultures. This is comparable to uptake for 
various cell lines, using THF as a solvent vehicle for carote-
noids [16]. Carotenoids might become associated with cell 
membranes and/or be taken up into the cytosol. Incorpora-
tion of carotenoids into the cell surface membrane might be 
important in inhibiting cell-mediated LDL oxidation. How-
ever, pre-incubation of HMM with zeaxanthin (25 mg/1) for 
18 h did not diminish their ability to oxidise LDL (data not 
shown). Thus scavenging of aqueous-phase radicals (e.g. thiyl 
radicals) by zeaxanthin seems a more likely explanation of this 
carotenoid's effect. 
The levels of incorporation of canthaxanthin, zeaxanthin 
and ß-carotene into LDL were respectively 198, 129 and 201 
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nmol/mg LDL protein, for a level of addition equivalent to 
final concentration in the cultures of 25 mg/1. Thus the com-
parative inefficiency of ß-carotene to inhibit oxidation when 
added via the LDL, rather than to the medium, was not due 
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Fig. 1. Effect of canthaxanthin on HMM-mediated oxidation of 
LDL. (a) Thiobarbituric acid-reactive substances (TBARS) expressed 
as equivalent nanomoles of malondialdehyde/mg LDL protein (cir-
cles), (b) relative electrophoretic mobility (REM) (squares) and 
(c) 7ß-hydroxycholesterol expressed as μg/mg LDL protein (trian-
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same experiment. The data are from one experiment representative 
of three. 
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Fig. 2. Effect of zeaxanthin on HMM-mediated oxidation of LDL. 
Other details are as in the legend to Fig. 1. 
to lack of incorporation. The lower level of incorporation of 
zeaxanthin than canthaxanthin into LDL is in keeping with 
the former being more effective at inhibiting LDL oxidation 
when added to the medium, whereas the latter was more ef-
fective when added via the LDL. 
Levels of ß-carotene, canthaxanthin and zeaxanthin, meas-
ured by HPLC, declined in the extracellular culture medium 
during oxidation of LDL (data not shown). Likewise, falls in 
the lower levels of endogenous carotenoids were reported in 
copper-catalysed LDL oxidation [3]. In the present study, de-
pletion was more marked in the situation where the carote-
noid was acting more effectively as a radical scavenger, i.e. ß-
carotene and zeaxanthin were more depleted when added di-
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Fig. 3. Effect of ß-carotene on HMM-mediated oxidation of LDL. 
Other details are as in the legend to Fig. 1. 
rectly into the medium than via the LDL, whereas cantha-
xanthin was more depleted when it was added via the LDL. 
Previous studies have investigated ß-carotene, but no other 
carotenoids, for potential inhibition of LDL oxidation. Some 
ex vivo measurements of LDL from volunteers receiving oral 
ß-carotene supplements and of LDL supplemented with ß-
carotene in vitro revealed no prolongation of the lag phase 
(234 nm absorbance) of copper-catalysed LDL oxidation 
[9,12,13]. However, Jialal and colleagues found that addition 
of ß-carotene in vitro inhibited LDL oxidation mediated by 
copper or HMM [25]. The lack of effect of ß-carotene in some 
studies [9,12,13] might be due to harshness of the in vitro 
oxidation conditions, obliterating any protective effect of ß-
carotene, as carotenoids are susceptible to breakdown under 
oxidative stress. 
Lipid peroxyl radicals (ROO'), thiyl radicals (RS'), and 
Superoxide radical cation (02~) are believed important in 
macrophage-mediated LDL oxidation [8], and there is evi-
dence that ß-carotene can scavenge these radicals by forming 
ß-carotene-radical adducts [1,26,27]. Canthaxanthin and zea-
xanthin may behave likewise. All three carotenoids slowed 
peroxidation of methyl linoleate, canthaxanthin being the 
most potent of the three [23]. Mechanisms of radical scaven-
ging by carotenoids are complex and incompletely under-
stood, although the common feature appears that the caroten-
oid molecule itself becomes a radical, the unpaired electron of 
which is highly delocalised over the conjugated polyene chro-
mophore, thereby having a stabilising effect [2]. The efficacy of 
individual carotenoids for radical scavenging depends on the 
particular system, presumably because multiple factors are 
involved, regarding both the radical being scavenged and 
the carotenoid itself, including steric considerations, electronic 
charge distribution, nature of solvent and microenvironment 
[23,28-30]. Thus a dietary intake of mixed carotenoids might 
be better than one dominated by an individual carotenoid, 
since in vivo a variety of radicals and local microenvironments 
will be encountered. Similar behaviour of ß-carotene and its 
3,3'-diol, zeaxanthin, in this and other studies, is in keeping 
with similarities in electron density profiles, and consequently 
similar chromophores, of these two compounds [2]. For 
canthaxanthin, the electron-withdrawing conjugated keto 
groups at C-4 and C-4' cause substantial changes in electron 
density along the polyene chain, especially near the end 
groups [2], partly explaining why canthaxanthin behaves dif-
ferently from zeaxanthin and ß-carotene [23,28]. 
Carotenoid radicals are short-lived and oxidative break-
down eventually produces non-radical products, with result-
ant bleaching due to breaking of the chromophore [2]. Car-
otenoids are reportedly better radical scavengers at low pC>2 
[1], which may be relevant in tissues such as artery walls, 
arterial blood having a p 0 2 of 95 mm Hg (i.e. 12.5% oxygen) 
[31], cf. 20.9% oxygen for atmospheric air. Within the artery 
wall, and within lesions, p 0 2 may or may not be lower than 
that of blood [32,33]. Carotenoids can also act as pro-oxi-
dants, especially at high concentration and high p 0 2 [1,2]. 
In vivo, oc-tocopherol and carotenoids might be complement-
ary, being respectively effective at high and low p 0 2 [1]. 
LDL oxidation in vitro is probably much harsher than in 
atherosclerotic lesions, which evolve over decades, whereas 
experiments take only 24 h. Moreover the overall degree of 
oxidation in the lesion appears to be much less than attained 
by LDL oxidation in vitro, judged by the levels of oxidised 
lipids [20,34,35], e.g. the level of 7ß-hydroxycholesterol in le-
sions is ca. 0.1 μg/100 μg cholesterol, whereas it is about 100-
fold higher in LDL oxidised by HMM or copper for 24 h 
[20,34,35]. Studies of LDL isolated from atherosclerotic le-
sions suggest only a modest degree of oxidation [36]. How-
ever, 'hot spots' of oxidation might occur in microenviron-
ments not apparent on analysis of bulk lesion contents. 
Although carotenoids are less abundant than ot-tocopherol 
in plasma lipoproteins, they may still play a complementary 
role in scavenging radicals, slowing lipoprotein oxidation in 
the lesion and thus retarding lesion progression. Cholesterol 
oxidation in lesions is also caused by cytochrome P-450 sterol 
26-hydroxylase (also termed sterol 27-hydroxylase) [34,35]; 
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the effects of carotenoids on this enzyme are untested. Besides 
their antioxidant properties, carotenoids have other biological 
activities, including inhibition of cell proliferation and en-
hancement of the immune system [37], which might affect 
atherosclerosis progression. 
This study showed that ß-carotene, canthaxanthin and 
zeaxanthin all inhibited HMM-media ted L D L oxidation in 
vitro, supporting the idea that diets rich in carotenoids might 
help slow the progression of arterial disease. 
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